New Jersey Administrative Code › Title 10 - HUMAN SERVICES › Chapter 161B - STANDARDS FOR LICENSURE OF OUTPATIENT SUBSTANCE USE DISORDER TREATMENT FACILITIES › Subchapter 11 - OPIOID TREATMENT SERVICES › Section 10:161B-11.15 - Clinic based medical maintenance

Current through Register Vol. 56, No. 14, July 15, 2024
(a) An opioid
				treatment program may elect to provide on-site clinic based medical maintenance
				services to Phase VI clients under the care of a licensed opioid treatment
				program physician according to program policy and the provisions of this
				chapter.
(b) Prior to initiating
				clinic based medical maintenance, an opioid treatment program shall:
1. Submit a written notice to DMHAS of its
				intent to initiate clinic based medical maintenance to Phase VI clients who
				meet the criteria in (c) below. The opioid treatment program shall identify the
				physician who will direct the clinic based medical maintenance program and
				submit documentation of the physician's qualifications to oversee the
				program;
2. Provide written
				assurance that counseling services, drug screenings and ancillary services will
				be provided as needed in accordance with this chapter;
3. Provide written assurance that the opioid
				treatment program can demonstrate internal protocols for reviewing client
				eligibility for clinic based medical maintenance utilizing a multidisciplinary
				team approach to minimally include: the program's medical director, director of
				substance abuse counseling, director of nursing services and the client's
				counselor;
4. Have been licensed
				and approved by all State and Federal authorities to operate an opioid
				treatment program for at least two years;
5. Be in substantial compliance with all
				State and Federal rules and regulations governing opioid treatment programs
				including this chapter and standards set by accrediting agencies;
6. Ensure that all clients in Phase VI
				designated for clinic based medical maintenance who are receiving monthly
				take-homes are seen monthly by the designated program physician;
7. Ensure that clients in clinic based
				medical maintenance receive monthly drug screening and an additional two
				special call backs in the first year, with subsequent call backs as determined
				by program policy for determining client responsibility in handling extended
				take-homes and drug screening at the time of the special call backs;
				and
8. Ensure that clients in
				clinic based medical maintenance with a positive urine screening result shall
				be assessed by the physician, in consultation with the multidisciplinary team,
				to determine if the client has been responsible in handling take home
				medication, and can be retained in medical maintenance based on an assessment
				of other client factors for stability. The physician shall refer the client for
				counseling in accordance with the provisions of this subchapter. Clients
				determined to have not been responsible in handling extended take-home
				medication shall be removed from clinic based medical maintenance. A second
				positive urine screening within 12 months shall result in the client being
				removed from clinic based medical maintenance and returned to the general
				program.